In the News

This risk assessment planner provides an estimate that answers the following question: what is the chance that one (or more) individuals is infected with COVID-19 in a group of a given size?

The bacteria that cause tooth decay protect themselves by hiding in a multilayered community of other bacteria and polymers, researchers in the US have found.

Now, some researchers are looking into “immunity shields” — a system in which people likely to be immune perform higher-risk jobs. This would shield non-immune workers from infection while allowing important services to resume.

Georgia Tech President Angel Cabrera portrays a new e-learning program on sustainability as a result of the type of university-based global coalition needed to solve big problems in the 21st century. “Global collaboration is essential, as is local action,” Cabrera said. “This situation we’re in is teaching us that, to make a difference, we have to collaborate globally while acting locally to find new approaches that none of us, alone, could come up with.”

Stephen Beckett and Joshua S. Weitz: "There’s a lag between when COVID-19 is found and when we know about it." Related coverage on Business Insider.

Three years ago, Kim Cobb was feeling “completely overwhelmed” by the problem of climate change. Cobb spends her days studying climate change as director of the Global Change Program at Georgia Tech in Atlanta, but she felt paralyzed over how to be part of the solution in her personal life. The barriers felt immense. She decided to start small.

A choreography of swimming, walking and rolling could help future rovers, built by Daniel Goldman's lab, avoid getting stuck in loose soil on the moon or Mars. Also featured on CNN, Science News, Inside Science, AAAS, Space.com, Daily Mail, Inverse, IEEE Spectrum, IHS Engineering360, Stars and Stripes.

The "Mini Rover," a scaled down 3D-printed model of a NASA rover concept, has a gait that allows it to crawl and successfully conquer tricky terrain.

A new test being used to test blood for COVID-19 antibodies is a new weapon being released in the battle against the deadly virus. “So if you have antibodies to the virus right now we can only tell you that you’ve been affected by the virus,” Dr. M.G. Finn said.

While attention remains focused on the number of COVID-19 deaths and new cases, a separate statistic – the number of recovered patients – may be equally important to the goal of minimizing the pandemic’s infection rate as shelter-in-place orders are lifted. “Our model describes ways in which serological tests used to identify individuals who have been infected by and recovered from COVID-19 could help both reduce future transmission and foster increased economic engagement,” said Joshua Weitz.